Introduction
Traditional Chinese medicine prescriptions have been used for over 1000 years, and in recent years concentrated dosage forms have been widely adopted for clinical use. The traditional Chinese medicine Radix Stephaniae tetrandrae (Chinese name: Fangji), the root of Stephaniae tetrandrae S. Moore, has been demonstrated to have pain-relieving, blood pressure-depressing, antiphlogistic, antineoplastic and antibiotic activities. It has been used clinically in China for centuries in the treatment of many diseases. 1 The main active constituents in Radix Stephaniae tetrandrae are two bisbenzylisoquinoline alkaloids, fangchinoline (FAN) and tetrandrine (TET). TET (its chemical structure is shown in Fig. 1 ) was best characterized as a Ca 2+ -entry blocker. It exhibits numerous pharmacological activities, including a modulating effect on cardiovascular disorders and anti-tumor and anti-inflammatory effects. 2 Human serum albumin (HSA) is the most abundant protein in the circulatory system; it plays an important role in the transport and deposition of many drugs in blood. 3, 4 Since the overall distribution, metabolism and efficacy of many drugs in the body are correlated with their affinities towards serum albumin, the information on the interaction of serum albumin and a particular drug can make people better understand the absorption and distribution of the drug. The investigation of pharmaceuticals with respect to albumin-drug binding is imperative and of fundamental importance. Extensive investigations into the interaction between the serum albumin and internal compound or pharmaceutical molecules have been made. [3] [4] [5] [6] [7] But so far only a few reports on the reactions between the effective component in Chinese herbal medicines and serum albumin have been reported. [8] [9] [10] Fluorescence spectroscopy (FS) and ultraviolet spectroscopy (UV) have been widely used to study the interactions between the small molecules and bio-macromolecules. [3] [4] [5] [6] [7] [8] [9] [10] From the measurements and analyses of the fluorescence emission spectra, the fluorescence lifetime, fluorescence polarization, etc., a vast amount of information can be procured about the structural fluctuations and the microenvironment changes surrounding the fluorophore in the macromolecule. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] In this study, the interaction of TET with HSA has been investigated by using FS and UV. The experimental results showed that TET could quench the inner fluorescence of HSA and that both static quenching and non-radiation energy transfer were the main reasons resulting in the fluorescence quenching. Moreover, the conformational changes of HSA were evaluated by synchronous fluorescence. In addition, the binding constants and the thermodynamic parameters of the process were also proposed in this work. To our knowledge, this is the first report about interactions of TET with HSA.
Experimental

Reagents
TET was purchased from the National Institute for The interaction of tetrandrine with human serum albumin (HSA) was studied by measuring fluorescence quenching spectra, synchronous fluorescence spectra and ultra-violet spectra. The fluorescence quenching spectra of HSA in the presence of tetrandrine showed that tetrandrine quenched the fluorescence of HSA. The quenching constants of tetrandrine on HSA were determined using the Stern-Volmer equation. Static quenching and non-radiation energy transfer were the two main reasons leading to the fluorescence quenching of HSA by tetrandrine. According to the Förster theory of nonradiation energy transfer, the binding distances (r) and the binding constants (KA) were obtained. The thermodynamic parameters obtained in this study revealed that the interaction between tetrandrine and HSA was mainly driven by a hydrophobic force. The conformational changes of HSA were investigated by synchronous spectrum studies. All other chemicals were of analytical reagent grade and all solutions were prepared with doubly distilled water.
Apparatus
A Hitachi F-4500 fluorescence spectrophotometer equipped with a 1.0 cm quartz cell and a thermostat bath was used to measure the fluorescence spectra and the fluorescence intensity. Fluorescence quenching spectra were obtained by recording the fluorescence emission wavelengths from 300 to 500 nm at the excitation wavelength of 283 nm, with the slit width of 5.0 nm. The synchronous fluorescence spectroscopy was scanned at Δλ = 15 nm and Δλ = 60 nm (Δλ = λem -λex). The UV-vis absorption spectra were recorded with a UV-250 recording spectrophotometer (Shimadzu).
Spectroscopic measurements
Appropriate quantities of TET (1.0 mg ml -1 ) ethanol solution were transferred to a 10 ml flask and evaporated to dryness; to this 5.0 ml of 1.0 × 10 -5 mol l -1 HSA solution was added. The resultant mixture was subsequently ultrasonicated for 5 min and incubated at 27, 37 or 47˚C for 2 h. A blank system containing 5.0 ml 1.0 × 10 -5 mol l -1 HSA solution alone was prepared similarly.
Fluorescence quenching spectra, fluorescence intensity and synchronous spectra were obtained with fluorescence spectrophotometer.
The absorption spectrum curves were obtained by scanning the 1.0 × 10 -5 mol l -1 TET solution prepared in pH 7.4 Tris-HCl buffer solution from 300 to 500 nm at 27, 37 or 47˚C, respectively.
Results and Discussion
Fluorescence quenching spectra and quenching mechanisms Figure 2 shows the emission spectra of HSA in the presence of various concentrations of TET. We observed that the fluorescence intensity of HSA decreased regularly with increased concentration of TET, and that there was no significant λem shift with the addition of TET, which indicated that TET could quench the inner fluorescence of HSA and that the interaction between TET and HSA indeed existed.
Quenching can occur by different mechanisms, usually classified as dynamic quenching or static quenching. Dynamic and static quenching can be distinguished by their different dependences on temperature and excited-state lifetime. Dynamic quenching depends upon diffusion. Since high temperatures will result in large diffusion coefficients, the bimolecular quenching constants are expected to increase with increased temperatures. If the KSV decreased with increased temperatures, it could be concluded that the quenching process is not a dynamic quenching but a static quenching. [5] [6] [7] [8] For dynamic quenching, the mechanism can be described by the Stern-Volmer equation:
Here F0 represents the fluorescence intensities in the absence of quencher, F represents the corrected fluorescence intensities in the presence of quencher (the correction method is same as that early employed by us), 9 Kq is the quenching rate constant of the bimolecule, KSV is the dynamic quenching constant, τ0 is the average lifetime of the molecule without quencher (the τ0 for the biopolymer is often taken as 10 -8 s) 13, 14 and [Q] is the concentration of the quencher. In order to confirm the quenching mechanism, the procedure of the fluorescence quenching was first assumed to be dynamic quenching. Figure 3 displays the Stern-Volmer plots of the quenching of HSA by TET at different temperatures.
Based on the experimental data in Fig. 3 , the corresponding calculated dynamic quenching constants for the interaction between TET and HSA are shown in Table 1 .
According to the literature, 15, 16 for dynamic quenching, the maximum scatter collision quenching constant of various quenchers with the biopolymer is about 2.0 × 10 10 l mol -1 s -1 . Considering that in our experiment, the rate constant of the protein quenching procedure initiated by TET is much greater than 2.0 × 10 10 l mol -1 s -1 and that the KSV decreased with increased temperatures, it can be concluded that the quenching is not initiated by dynamic quenching, but probably by static quenching resulting from the formation of TET-HSA complexes.
Binding constants and binding sites
For static quenching, the relationship between fluorescence quenching intensity and the concentration of quenchers can be described by the following formula: 17, 18 log(F0 -
where KA is the binding constant, and n is the number of binding sites per HSA. After the fluorescence quenching intensities on HSA at 336 nm were measured, the double-logarithm algorithm was assessed by Eq. (2). Figure 4 shows the resulting doublelogarithm curves and Table 2 presents the corresponding calculated results. The linear correlation coefficients for the curves are larger than 0.990, indicating that the interaction between TET and HSA agrees well with the site-binding model underlying Eq. (2). The result illustrates that there is a strong binding force between TET and HSA, and that one binding site would be formed.
Binding distance between the drug and the amino acid residues of HSA
According to the Förster non-radiation energy transfer theory, 19, 20 the energy transfer effect is related not only to the distance between the acceptor and donor, but also to the critical energy-transfer distance (R0).
where E is the energy transfer efficiency, R0 is the critical distance when the transfer efficiency is 50%, and r is the binding distance between donor and acceptor.
where K 2 is the spatial orientation factor of the dipole, N is the refractive index of the medium, Φ is the fluorescence quantum yield of the donor, and J is the overlap integral of the fluorescence emission spectrum of the donor and the absorption spectrum of the acceptor. Therefore,
where IP(λ) is the fluorescence intensity of the fluorescence donor at wavelength λ, and εD(λ) is the molar absorptivity of the acceptor at wavelength λ. The overlap of the absorption spectrum of TET and the fluorescence emission spectrum of HSA is shown in Fig. 5 . The overlap integral was calculated to be 3.64 × 10 -15 cm 3 l mol -1 for TET-HSA system at 27˚C by integrating the spectra for 300 -500 nm in Fig. 5 . The critical distance, R0, corresponding to 50% energy transfer from HSA to TET was calculated to be 2.15 nm from Eq. (5) when K 2 = 2/3, N = 1.336, Φ = 0.15. 21, 22 The binding distance, r, between TET and the amino acid residue in HSA was found to be 3.00 (27˚C), 3.28 (37˚C), 3.51 (47˚C) (shown in Table 2 ), which are much smaller than 7 nm, a criterion value for energy transfer phenomenon to occur, 19, 20 suggesting that the energy transfer from HSA to TET may occur with high possibility.
Thermodynamic parameters and nature of the binding forces
The interaction forces between drug and biomolecule may involve hydrophobic force, electrostatic interactions, van der Waals interactions, hydrogen bonds, etc. In order to elucidate the interaction of TET with HSA, we calculated the thermodynamic parameters from Eqs. (7) - (9) .
If the temperature does not vary significantly, the enthalpy change (ΔH) can be regarded as a constant. The free energy change (ΔG) can be estimated from the following equation based on the binding constants at different temperatures:
where R is the gas constant, T is the experimental temperature, and K is the binding constant at the corresponding T. Then, the enthalpy change (ΔH) and entropy change (ΔS) can be calculated from the following equations:
The thermodynamic parameters for the interaction of TET with HSA are shown in Table 3 . The negative sign for ΔG 
Conformational studies
The synchronous fluorescence spectra can provide information about the molecular environment in the vicinity of the chromosphere molecules. In the synchronous fluorescence spectra, the sensitivity associated with fluorescence is maintained while several advantages are available: spectral simplification, spectral bandwidth reduction, and avoidance of different perturbing effects. The conformational changes of HSA caused by TET were evaluated by measuring the synchronous fluorescence intensity of HSA before and after the addition of TET. In this work, the synchronous fluorescence characteristics of HSA were studied at different scanning intervals Δλ (Δλ = λem -λex). According to the literature, 24 when Δλ = 15 nm, the spectral characteristics of tyrosine residues in HSA can be observed, and when Δλ = 60 nm, the spectral characteristics of tryptophan residues in HSA can be observed. A useful method of studying the environment of amino acid residues was to measure the possible shift in fluorescence emission wavelength maximum λmax. The shift in the position of fluorescence emission maximum corresponds to the changes of the polarity around the chromophore molecule. A blue shift of λmax means that the amino acid residues are located in a more hydrophobic environment, and are less exposed to the solvent, and a red shift of λmax implies that the amino acid residues are in a polar environment, and are more exposed to the solvent. [25] [26] [27] Thus, the conformational changes of HSA can be evaluated by the measurement of λmax changes.
With the HSA concentration being unchanged and the concentration of TET being increased, the synchronous fluorescence spectroscopy was scanned at Δλ = 15 nm and Δλ = 60 nm. The effects of TET on HSA synchronous fluorescence spectroscopy are shown in Fig. 6 .
The effect of TET on the fluorescence intensity of the tyrosine (Fig. 6A ) and tryptophan residues (Fig. 6B) of HSA indicated that the main contributions to the fluorescence intensity of HSA resulted from tryptophan residues, since the fluorescence emission wavelength maximum of tryptophan residues was close to that of HSA, and the fluorescence intensity of tryptophan residues was much bigger than that of tyrosine residues. However, the interaction of tyrosine with TET could not be excluded, as both the fluorescence of tryptophan and tyrosine residues were quenched by TET.
It is also observed from Fig. 6 that, upon the addition of the drug, there is a small red-shift of the maximum emission wavelength of tyrosine residues (Fig. 6A) , and that there are great changes of the peak shape and strong blue-shifts of the maximum emission wavelength of tryptophan residues (Fig.  6B) , suggesting that the interaction of HSA by TET resulted in a more polar environment for tyrosine residues, and a more hydrophobic environment for tryptophan residues. The above results indicate that TET could insert in HSA molecules and result in molecular conformational changes of HSA.
Conclusions
In this paper, we have investigated the nature and magnitude of the interaction of HSA with TET by fluorescence spectra, and UV-vis spectra. The results showed that the Stern-Volmer quenching constant KSV is inversely correlated with temperature, which indicated that the probable quenching mechanism of the HSA-TET system is initiated by static quenching. The thermodynamic parameters showed that the interaction between TET and HSA is spontaneous, and that the hydrophobic force is a major factor in the interaction. A blue shift of the maximum wavelength emission of HSA from synchronous fluorescence spectra suggested that TET could cause a more hydrophobic environment for the tryptophan residues in HSA and would result in conformational changes of HSA.
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